IRMD vs. SYK

Last updated Jun 3, 2026

IRMD (IRadimed Corporation) and SYK (Stryker Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, IRMD returned 17.93%/yr vs 11.18%/yr for SYK. At a 0.22 correlation, their price movements are largely independent.

Performance

IRMD vs. SYK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IRadimed Corporation (IRMD) and Stryker Corporation (SYK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IRMD achieves a -7.24% return, which is significantly higher than SYK's -16.32% return. Over the past 10 years, IRMD has outperformed SYK with an annualized return of 17.93%, while SYK has yielded a comparatively lower 11.18% annualized return.

IRMD

• 1D: -2.38%
• 1M: 3.35%
• YTD: -7.24%
• 6M: -1.47%
• 1Y: 57.66%
• 3Y*: 24.41%
• 5Y*: 28.64%
• 10Y*: 17.93%

SYK

• 1D: -2.06%
• 1M: -0.49%
• YTD: -16.32%
• 6M: -19.60%
• 1Y: -22.25%
• 3Y*: 2.76%
• 5Y*: 4.34%
• 10Y*: 11.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IRMD vs. SYK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IRMD IRadimed Corporation	-7.24%	79.69%	16.99%	75.37%	-37.53%	102.68%	-2.48%	-4.42%	61.45%	36.49%
SYK Stryker Corporation	-16.32%	-1.48%	21.34%	23.80%	-7.42%	10.22%	18.17%	35.33%	2.43%	30.84%

Correlation

The correlation between IRMD and SYK is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (10Y) Calculated over the trailing 10-year period	0.24
Correlation (All Time) Calculated using the full available price history since Jul 17, 2014	0.22

Fundamentals

Market Cap IRMD : $1.16B SYK : $113.36B
EPS IRMD : $1.84 SYK : $8.63
PE Ratio IRMD : 48.94 SYK : 33.97
PEG Ratio IRMD : 2.04 SYK : 2.52
PS Ratio IRMD : 13.39 SYK : 4.49
PB Ratio IRMD : 11.74 SYK : 2.45
Total Revenue (TTM) IRMD : $86.28M SYK : $25.27B
Gross Profit (TTM) IRMD : $66.30M SYK : $16.09B
EBITDA (TTM) IRMD : $30.55M SYK : $5.48B

Return for Risk

IRMD vs. SYK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IRMD

IRMD Risk / Return Rank: 82
IRMD Sharpe Ratio Rank: 84
IRMD Sortino Ratio Rank: 83
IRMD Omega Ratio Rank: 81
IRMD Calmar Ratio Rank: 80
IRMD Martin Ratio Rank: 83

SYK

SYK Risk / Return Rank: 6
SYK Sharpe Ratio Rank: 4
SYK Sortino Ratio Rank: 6
SYK Omega Ratio Rank: 8
SYK Calmar Ratio Rank: 11
SYK Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IRMD vs. SYK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IRMD	SYK	Difference
Sharpe ratio Return per unit of total volatility	1.72	-1.01	+2.73
Sortino ratio Return per unit of downside risk	2.63	-1.38	+4.01
Omega ratio Gain probability vs. loss probability	1.32	0.84	+0.48
Calmar ratio Return relative to maximum drawdown	2.79	-0.77	+3.55
Martin ratio Return relative to average drawdown	8.18	-1.92	+10.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IRMD vs. SYK - Sharpe Ratio Comparison

The current IRMD Sharpe Ratio is 1.72, which is higher than the SYK Sharpe Ratio of -1.01. The chart below compares the historical Sharpe Ratios of IRMD and SYK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IRMD	SYK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.72	-1.01	+2.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.66	0.18	+0.48
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.37	0.43	-0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.55	-0.13

Drawdowns

IRMD vs. SYK - Drawdown Comparison

The maximum IRMD drawdown since its inception was -75.83%, which is greater than SYK's maximum drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for IRMD and SYK.

Drawdown Indicators

	IRMD	SYK	Difference
Max Drawdown Largest peak-to-trough decline	-75.83%	-58.63%	-17.20%
Max Drawdown (1Y) Largest decline over 1 year	-20.62%	-29.45%	+8.83%
Max Drawdown (3Y) Largest decline over 3 years	-26.28%	-29.45%	+3.17%
Max Drawdown (5Y) Largest decline over 5 years	-49.38%	-31.68%	-17.70%
Max Drawdown (10Y) Largest decline over 10 years	-64.30%	-43.80%	-20.50%
Current Drawdown Current decline from peak	-14.31%	-26.77%	+12.46%
Average Drawdown Average peak-to-trough decline	-28.09%	-13.10%	-14.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.02%	11.76%	-4.74%

Volatility

IRMD vs. SYK - Volatility Comparison

The current volatility for IRadimed Corporation (IRMD) is 7.97%, while Stryker Corporation (SYK) has a volatility of 8.61%. This indicates that IRMD experiences smaller price fluctuations and is considered to be less risky than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IRMD	SYK	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.97%	8.61%	-0.64%
Volatility (6M) Calculated over the trailing 6-month period	21.34%	17.77%	+3.57%
Volatility (1Y) Calculated over the trailing 1-year period	33.78%	22.03%	+11.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.56%	24.13%	+19.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.58%	26.31%	+22.27%

Dividends

IRMD vs. SYK - Dividend Comparison

IRMD's dividend yield for the trailing twelve months is around 1.38%, more than SYK's 1.17% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IRMD IRadimed Corporation	1.38%	1.21%	0.82%	3.54%	3.53%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SYK Stryker Corporation	1.17%	0.97%	0.90%	1.02%	1.16%	0.97%	0.96%	1.02%	1.23%	1.13%	1.31%	1.52%

Financials

IRMD vs. SYK - Profitability Comparison

The chart below illustrates the profitability comparison between IRadimed Corporation and Stryker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

IRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported a gross profit of 16.81M and revenue of 21.98M. Therefore, the gross margin over that period was 76.5%.

SYK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported a gross profit of 3.81B and revenue of 6.02B. Therefore, the gross margin over that period was 63.3%.

IRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported an operating income of 7.24M and revenue of 21.98M, resulting in an operating margin of 32.9%.

SYK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported an operating income of 936.00M and revenue of 6.02B, resulting in an operating margin of 15.6%.

IRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported a net income of 5.82M and revenue of 21.98M, resulting in a net margin of 26.5%.

SYK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported a net income of 745.00M and revenue of 6.02B, resulting in a net margin of 12.4%.

Frequently Asked Questions

Can I hold both IRMD and SYK in my portfolio?

IRMD and SYK have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IRMD or SYK?

SYK has higher volatility (8.61%) compared to IRMD (7.97%). In terms of maximum drawdown, IRMD dropped -75.83% vs SYK's -58.63%.

Which has better risk-adjusted returns?

IRMD currently has the higher Sharpe Ratio (1.72 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.